Improved Outcomes Associated with Limiting Identification of Candida spp. in Respiratory Secretions

Journal of Clinical Microbiology

Volumn 41, Issue 12, 2003, Pages 5645-5649

  Barenfanger, Joan ^a   Arakere, Pushpalatha ^b   Dela Cruz, Rafael ^b   Imran, Adil ^b   Drake, Cheryl ^a   Lawhorn, Jerry ^a   Verhulst, Steven J ^b   Khardori, Nancy ^b  

^a MEMORIAL MEDICAL CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ADULT; ARTICLE; CANDIDA; CANDIDIASIS; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG USE; FEMALE; FUNGUS IDENTIFICATION; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG FLUID; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; UNITED STATES;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CANDIDA; CANDIDIASIS; CORONARY DISEASE; HOSPITALS, TEACHING; HUMANS; HYPERTENSION; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

CANDIDA; FUNGI;

EID: 0348109506     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.12.5645-5649.2003     Document Type: Article

References (20)

1. Azaz-Livshits, T., M. Levy, B. Sadan, M. Shalit, G. Geisslinger, and K. Brune. 1998. Computerized surveillance of adverse drug reactions in hospital. Br. J. Clin. Pharmacol. 45:309-314.
2. Carroll, K. 2002. Laboratory diagnosis of lower respiratory tract infections: controversy and conundrums. J. Clin. Microbiol. 40:3115-3120.
3. Cunha, B. A. 2001. Pneumonias in the compromised host. Infect. Dis. Clin. N. Am. 15:591-612.
4. El-Ebiary, M., A. Torres, N. Fabregas, J. P. de la Bellacasa, J. Gonzalez, J. Ramirez, D. del Bano, C. Hernandez, and M. T. Jimenez de Anta. 1997. Significance of the isolation of Candida species from respiratory sample in critically ill, non-neutropenic patients: an immediate postmortem histologic study. Am. J. Respir. Crit. Care Med. 156:583-590.
5. Hasford, J., M. Goettle, K. H. Munter, and B. Muller-Oerlinghausen. 2002. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J. Clin. Epidemiol. 55:945-950.
6. Khong, T. K., and D. R. Singer. 2002. Adverse drug reactions: current issues and strategies for prevention and management. Exp. Opin. Pharmacother. 3:1289-1300.
7. Martin, R., K. Kapoor, L. V. Wilton, and R. D. Mann. 1998. Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study. Br. Med. J. 317:119-120.
8. Martinez, M., J. L. Lopez-Ribot, W. R. Kirkpatrick, B. J. Coco, S. P. Bachmann, and T. F. Patterson. 2002. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J. Clin. Microbiol. 40:3135-3139.
9. McAdams, H. P., M. L. Rosado-de-Cristenson, P. A. Templeton, M. Lesar, and C. A. Moran. 1995. Thoracic mycosis from opportunistic fungi: radiologic-pathologic correlation. Radiographics 15:271-286.
10. Murray, P. R., R. E. Van Scoy, and G. Roberts. 1977. Should yeasts in respiratory specimens be identified? Mayo Clin. Proc. 52:42-45.
11. Nguyen, M. H., J. E. Peacock, A. J. Morris, D. C. Tanner, M. L. Nguyen, D. R. Snydman, M. M. Wagener, M. G. Rinaldi, and V. L. Yu. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance Am. J. Med. Med. 100:617-623.
12. Onder, G., C. Pedone, F. Landi, M. Cesari, C. Della Vedova, R. Bernabei, and G. Gambassi. 2002. Adverse drug reactions as cause of hospital admissions: results from the Italian group of pharmacoepidemiology in the elderly (GIFA). J. Am. Geriatr. Soc. 50:1962-1966.
13. Peyriere, H., S. Cassan, E. Floutard, S. Riviere, J. P. Blayac, D. Hillaire-Buys, A. Le Quellec, and S. Hansel. 2003. Adverse drug events associated with hospital admission. Ann. Pharmacother. 37:5-11.
14. Pfaller, M. A., R. N. Jones, S. A. Messer, M. B. Edmond, and R. P. Wensel. 1998. National surveillance of nosocomial bloodstream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility inthe SCOPE program. Diagn. Microbiol. Infect. Dis. 31:327-332.
15. Pfaller, M. A., R. N. Jones, S. A. Messer, M. B. Edmond, and R. P. Wensel. 1998. National surveillance of nosocomial bloodstream infection due to Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn. Microbiol. Infect. Dis. 30:121-129.
16. Rello, J., M. Esandi, E. Diaz, D. Marsical, M. Gallego, and J. Valles. 1998. The role of Candida sp. isolated from bronchoscopic samples in non-neutropenic patients. Chest 114:146-149.
17. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
18. Saccenete, M. 2002. Fungal pneumonia: epidemiology, diagnosis and management. Res. Staff Phys. 48:50-58.
19. Vargas, E., A. Terleira, F. Hernando, E. Perez, C. Cordon, A. Moreno, and A. Portole. 2003. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit. Care Med. 31:694-698.
20. Von Eiff, M., M. Zuhlsdorf, N. Roos, M. Hesse, R. Schulten, and J. van de Loo. 1995. Pulmonary fungal infections in patients with hematological malignancies - diagnostic approaches. Ann. Hematol. 70:135-141.